H. Fai Poon

H. Fai Poon

Auto-generated profile, based on publicly available information

H. Fai Poon

Research and Development Department,Quacell Biotechnology Co., Ltd., Zhongshan, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Tissue and Cell
Verified
Journal Article
Closed access
WXWenyan Xu
Wenyan Xu
XYXiaoyu Yu
Xiaoyu Yu
JZJiewei Zhang
Jiewei Zhang
SBSasi Bhushan
Sasi Bhushan
SPSiddalinga Prasad
Siddalinga Prasad
HPH. Fai Poon
H. Fai Poon

25 June 2020 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
WXWayne Wen-Yan Xu
Wayne Wen-Yan Xu
JYJun Yuan
Jun Yuan
WGWeilun Gong
Weilun Gong
GXGuohao Xie
Guohao Xie
YMYingyin Ma
Yingyin Ma
HPH. Fai Poon
H. Fai Poon
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

30 June 2023 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
HPH. Fai Poon
H. Fai Poon
JYJun Yuan
Jun Yuan
WXwayne xu
wayne xu
AWAlan F Wu
Alan F Wu
HYHenry X Yu
Henry X Yu
This chapter discusses the molecular basis of learning and memory, specifically the Hebbian theory, which suggests that coincident activation of pre- and postsynaptic neurons leads to modifications in synaptic efficacy, creating associative links between the neurons. Memories are stored as alterations of these synaptic changes. The chapter will also discuss three basic assumptions regarding the neurochemical basis of learning and memory, including the requirement for protein synthesis for long-term memory formation, and the storage of memory in synaptic connections. The passage also discusses long-term potentiation (LTP) as the most frequently studied cellular basis of learning and memory in vertebrates, including its properties such as state-dependence, input specificity, and associativity. LTP is considered an analog of memory since it is a long-lasting alteration in neuronal function that results from a brief period of stimulus.

30 June 2025 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
WXWenyan Xu
Wenyan Xu
BZBo Zou
Bo Zou
GXGuohao Xie
Guohao Xie
YWYeqing Wu
Yeqing Wu
HPH. Fai Poon
H. Fai Poon
Cell culture plays a pivotal role in the biomedical industry, with a growing shift from traditional serum-containing adherent systems to serum-free suspension culture platforms. This transition underscores the importance of developing robust cell suspension adaptation protocols and serum-free culture media to meet industrial demands. In this study, we employed a combination of cell suspension acclimation, differential screening of culture media, and factorial design methodology to rapidly adapt adherent human embryonic kidney (HEK293) cells to suspension culture. Additionally, we developed a chemically defined medium optimized for these cells within a short timeframe. By systematically adjusting the concentrations of key medium components and integrating an optimized adaptation protocol, we successfully achieved efficient suspension culture of HEK293 cells. Notably, this approach significantly reduced cell aggregation and enhanced cell growth density, thereby advancing the potential for industrial-scale applications.

30 December 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
YWYeQing Wu
YeQing Wu
GXGuoHao Xie
GuoHao Xie
WXWeiXian Xu
WeiXian Xu
JYJun Yuan
Jun Yuan
WXWayne Wenyan Xu
Wayne Wenyan Xu
HPH. Fai Poon
H. Fai Poon
Adeno-associated viruses (AAVs) have proven to be effective tools for gene therapy due to their ability to be engineered to deliver genetic material to target cells. This study investigates the performance of three different filtration membrane packs—Lepure, Cobetter, and Merck—in purifying the AAV8 serotype. We assessed the turbidity and AAV titer before and after filtration to evaluate the efficiency of each membrane. Before filtration, the AAV8 sample exhibited a turbidity of 173.6 nephelometric turbidity units (NTU) and a titer of 1.01 × 1011 viral genomes per mL (vg/mL). Post-filtration, it is observed that the Lepure membrane achieved a turbidity of 6.65 NTU and an AAV titer of 4.48 × 109 vg/mL, while Cobetter resulted in a turbidity of 3.44 NTU and a titer of 3.80 × 109 vg/mL. Merck demonstrated the lowest performance with a turbidity of 0.49 NTU and an AAV titer of 9.70 × 109 vg/mL. Notably, Lepure demonstrated the highest recovery rate at 13.3%, despite its higher turbidity, indicating minimal viral adsorption. These findings highlight the importance of selecting appropriate filtration systems to optimize AAV recovery while maintaining low turbidity levels, ultimately enhancing the efficiency of AAV as a vector for therapeutic applications. Further research is recommended to refine these filtration methods to improve the purification of AAV.